wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26747768-3151CAF2-83B5-470F-A226-5CFCA41C26D9
Q26747768-3151CAF2-83B5-470F-A226-5CFCA41C26D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26747768-3151CAF2-83B5-470F-A226-5CFCA41C26D9
Clinical developments in the treatment of relapsed or relapsed and refractory multiple myeloma: impact of panobinostat, the first-in-class histone deacetylase inhibitor
P2860
Q26747768-3151CAF2-83B5-470F-A226-5CFCA41C26D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26747768-3151CAF2-83B5-470F-A226-5CFCA41C26D9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c19fc355a711570214b2a192e0d8cf2a0eae1518
P2860
Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies.